These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33965337)

  • 21. [Association between lifestyle factors assessed by standard question items of specific health checkup and the incidence of metabolic syndrome and hypertension in community dwellers: A five-year cohort study of National Health Insurance beneficiaries in Habikino City].
    Tsutatani H; Funamoto M; Sugiyama D; Kuwabara K; Miyamatsu N; Watanabe K; Okamura T
    Nihon Koshu Eisei Zasshi; 2017; 64(5):258-269. PubMed ID: 28626153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of the development of metabolic syndrome by the Markov model based on a longitudinal study in Dalian City.
    Tang X; Liu Q
    BMC Public Health; 2018 Jun; 18(1):707. PubMed ID: 29879952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and relationship between metabolic syndrome and risk of cardiovascular disease: Evidence from two population-based studies.
    Alieva AS; Olmastroni E; Reutova OV; Rotar OP; Konradi AO; Shlyakhto EV; Baragetti A; Grigore L; Pellegatta F; Casula M; Tragni E; Catapano AL
    Atheroscler Suppl; 2020 Dec; 42():e41-e48. PubMed ID: 33589223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic Syndrome During Menopause.
    Mumusoglu S; Yildiz BO
    Curr Vasc Pharmacol; 2019; 17(6):595-603. PubMed ID: 30179134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex-specific-evaluation of metabolic syndrome prevalence in Algeria: insights from the 2016-2017 non-communicable diseases risk factors survey.
    Ngwasiri C; Kinoré M; Samadoulougou S; Kirakoya-Samadoulougou F
    Sci Rep; 2023 Nov; 13(1):18908. PubMed ID: 37919315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between metabolic syndrome severity score and cardiovascular disease: results from a longitudinal cohort study on Chinese adults.
    Lin JJ; Dai PY; Zhang J; Guan YQ; Gong WW; Yu M; Fang L; Hu RY; He QF; Li N; Wang LX; Liang MB; Zhong JM
    Front Endocrinol (Lausanne); 2024; 15():1341546. PubMed ID: 38654930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of New Criteria for Metabolic Syndrome Optimized for Prediction of Cardiovascular Diseases in Japanese.
    Yamazaki Y; Fujihara K; Sato T; Harada Yamada M; Yaguchi Y; Matsubayashi Y; Yamada T; Kodama S; Kato K; Shimano H; Sone H
    J Atheroscler Thromb; 2024 Apr; 31(4):382-395. PubMed ID: 37981330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome clustering patterns and the association with cardiovascular disease among post-menopausal Korean women.
    Choi YJ; Kim GS; Chu SH; Lee KH; Park CG; Sohn M
    Sci Rep; 2024 Sep; 14(1):22702. PubMed ID: 39349570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender difference in metabolic syndrome and incident colorectal adenoma: A prospective observational study (KCIS No.42).
    Ku MS; Chiu SY; Chien KL; Lee YC; Chen SL; Chen CD
    Medicine (Baltimore); 2021 Jun; 100(22):e26121. PubMed ID: 34087861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of metabolic syndrome among diverse Hispanics/Latinos living in the United States: Latent class analysis from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Arguelles W; Llabre MM; Sacco RL; Penedo FJ; Carnethon M; Gallo LC; Lee DJ; Catellier DJ; González HM; Holub C; Loehr LR; Soliman EZ; Schneiderman N
    Int J Cardiol; 2015 Apr; 184():373-379. PubMed ID: 25745986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations between smoking, components of metabolic syndrome and lipoprotein particle size.
    Slagter SN; van Vliet-Ostaptchouk JV; Vonk JM; Boezen HM; Dullaart RP; Kobold AC; Feskens EJ; van Beek AP; van der Klauw MM; Wolffenbuttel BH
    BMC Med; 2013 Sep; 11():195. PubMed ID: 24228807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of metabolic syndrome over 9 years follow-up; the importance of sex differences in the role of insulin resistance and other risk factors.
    Hadaegh F; Hasheminia M; Lotfaliany M; Mohebi R; Azizi F; Tohidi M
    PLoS One; 2013; 8(9):e76304. PubMed ID: 24086723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease.
    Regitz-Zagrosek V; Lehmkuhl E; Mahmoodzadeh S
    Gend Med; 2007; 4 Suppl B():S162-77. PubMed ID: 18156101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: the suita study.
    Kokubo Y; Okamura T; Yoshimasa Y; Miyamoto Y; Kawanishi K; Kotani Y; Okayama A; Tomoike H
    Hypertens Res; 2008 Nov; 31(11):2027-35. PubMed ID: 19098374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic syndrome in haemodialysis patients: prevalence, determinants and association to cardiovascular outcomes.
    Delautre A; Chantrel F; Dimitrov Y; Klein A; Imhoff O; Muller C; Schauder N; Hannedouche T; Krummel T
    BMC Nephrol; 2020 Aug; 21(1):343. PubMed ID: 32792012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiovascular risk profile in 40-year old men and 50-year old women in the Czech Republic: results of a cross-sectional survey].
    Vrablík M; Chmelík Z; Lánská V
    Vnitr Lek; 2014 Nov; 60(11):991-7. PubMed ID: 25600047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age- and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome - A cross-sectional study.
    Moebus S; Balijepalli C; Lösch C; Göres L; von Stritzky B; Bramlage P; Wasem J; Jöckel KH
    Cardiovasc Diabetol; 2010 Aug; 9():34. PubMed ID: 20696055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic syndrome in Xinjiang Kazakhs and construction of a risk prediction model for cardiovascular disease risk.
    Mao L; He J; Gao X; Guo H; Wang K; Zhang X; Yang W; Zhang J; Li S; Hu Y; Mu L; Yan Y; Ma J; Ding Y; Zhang M; Liu J; Ma R; Guo S
    PLoS One; 2018; 13(9):e0202665. PubMed ID: 30188929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Metabolic Syndrome in Chinese Patients With Erythrodermic Psoriasis: A Case-Control Study.
    Ma AR; Liu F; Wang R; Lin L; Wang Y; Li Q; Lu X; Du J
    Front Endocrinol (Lausanne); 2021; 12():677912. PubMed ID: 34970217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of predictability of cardiovascular events between each metabolic component in patients with metabolic syndrome based on the revised National Cholesterol Education Program criteria.
    Hwang IC; Kim KK; Jee SH; Kang HC
    Yonsei Med J; 2011 Mar; 52(2):220-6. PubMed ID: 21319338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.